Senti Biosciences Holdings, Inc. Research And Development Expense

Quick Answer

Senti Biosciences Holdings, Inc. reported Research And Development Expense of $37.59 million for the year ending 2025.

  • Senti Biosciences Holdings, Inc. showed an increase of +9.4% in Research And Development Expense from 2024 to 2025.
  • This data is from Senti Biosciences Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), Senti Biosciences Holdings, Inc.'s Research And Development Expense has grown by 71.2%.
  • Historical annual values: Fiscal year 2025: $37.59 million | Fiscal year 2024: $34.36 million | Fiscal year 2023: $32.15 million | Fiscal year 2022: $28.15 million | Fiscal year 2021: $21.96 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: